Skip to main content

Table 1 Effect of silymarin on liver weight, liver weight/body weight ratio, body mass index, body weight gain

From: Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats

Group Weight measurement
Liver weight(g) Liver weight/body weight (g/g) Body mass index (kg/m2) Body Weight Gain(g)
NC 6.24 ± 0.53 0.025 ± 0.002 5.66 ± 0.18 71.67 ± 27.05
FC 6.98 ± 0.24* 0.029 ± 0.003 5.70 ± 0.39 79.67 ± 19.36
SC 6.34 ± 0.41 0.026 ± 0.002 5.65 ± 0.19 71.83 ± 9.15
FTH 6.71 ± 0.33 0.027 ± 0.003 5.81 ± 0.48 74.33 ± 17.67
FFH 6.50 ± 0.36 0.026 ± 0.004 5.75 ± 0.28 72.67 ± 25.90
  1. At the end of the trial liver weight, liver weight/body weight ratio, body mass index and body weight gain were measured and calculated. NC normal control, FC fructose control, SC silymarin control, FTH fructose + 200 mg/kg silymarin, FFH fructose + 400 mg/kg silymarin. Data were presented as mean ± SD. N = 6 for each group. * p < 0.05 vs. NC